NCT00049543 2015-01-01Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by SurgeryNational Cancer Institute (NCI)Phase 3 Completed503 enrolled 12 charts